Our portfolio company, LUNAPHORE, a Swiss life-sciences company developing innovative next-generation equipment for cancer research and tissue diagnostics, raised CHF 23M in a Series C funding round.
The round was led by global healthcare company PHC Holding Corporation that owns Epredia, a leading provider of comprehensive solution for precision cancer diagnostics. Alpana Ventures and other co-investors participated in this financing round.
LUNAPHORE will invest the proceeds in market and product expansion.
Alpana congratulates LUNAPHORE’s team for this achievement.
FOLLOW ALPANA NEWS:
Tour de l’Ile 1
CH – 1204 Geneva
+41 22 312 20 50
ENERGYPOLIS CAMPUS
Rue de l’Industrie 23
1950 Sion
Copyright 2023 by ALPANA VENTURES – Disclaimer
Cookie | Durée | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |